The aging gut microbiome and its impact on host immunity

• Published in: Genes and immunity Vol. 22; no. 5-6; pp. 289 - 303
• Main Authors: Bosco, Nabil, Noti, Mario
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 01.10.2021; Nature Publishing Group UK
• Subjects: Age; Aging; Care and treatment; Clinical trials; Community structure; Complications and side effects; Development and progression; Digestive system; Dysbacteriosis; Dysbiosis; Gastrointestinal Microbiome; Health aspects; Humans; Immune System; Immunosenescence; Infectious diseases; Intestinal microflora; Life span; Microbiomes; Microbiota; Microbiota (Symbiotic organisms); Physiological aspects; Probiotics; Review; Vaccination; Switzerland
• ISSN: 1466-4879; 1476-5470
• DOI: 10.1038/s41435-021-00126-8

The microbiome plays a fundamental role in the maturation, function, and regulation of the host-immune system from birth to old age. In return, the immune system has co-evolved a mutualistic relationship with trillions of beneficial microbes residing our bodies while mounting efficient responses to fight invading pathogens. As we age, both the immune system and the gut microbiome undergo significant changes in composition and function that correlate with increased susceptibility to infectious diseases and reduced vaccination responses. Emerging studies suggest that targeting age-related dysbiosis can improve health- and lifespan, in part through reducing systemic low-grade inflammation and immunosenescence-two hallmarks of the aging process. However-a cause and effect relationship of age-related dysbiosis and associated functional declines in immune cell functioning have yet to be demonstrated in clinical settings. This review aims to (i) give an overview on hallmarks of the aging immune system and gut microbiome, (ii) discuss the impact of age-related changes in the gut commensal community structure (introduced as microb-aging) on host-immune fitness and health, and (iii) summarize prebiotic- and probiotic clinical intervention trials aiming to reinforce age-related declines in immune cell functioning through microbiome modulation or rejuvenation.